Abstract
We estimate the U.S. temperature response curve for COVID-19 and show transmission is quite sensitive to temperature variation. This is despite summer outbreaks widely assumed to show otherwise. By largely replacing the death counts states report daily, with counts based on death certificate date, we build a week-ahead statistical forecasting model that explains most of the daily variation (R2 = 0.97) and isolates COVID-19’s temperature response profile (p < 0.001). These counts normalized at 31°C (U.S. mid-summer average) scale up nearly 160% at 5°C. Positive cases are more temperature sensitive; scaling up by almost 400% between 31°C and 5°C. Dynamic feedback amplifies these effects. There is a short window to get COVID-19 under control before cooler weather makes the task substantially more challenging.
Significance Statement COVID-19 transmission, in the form of daily state-level death counts and positive cases, ramps up and down with changes in maximum daily temperature. This relationship, known as COVID-19’s temperature response profile, is reliably estimated by assembling a new dataset that largely repairs the sizable divergence between when COVID-19 deaths occur and when they are reported. Over time this effect is can be quite large and, as such, important to efforts to forecast and manage COVID-19.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
Epidemiology study based on publicly available (non-individually identified) data.
Funding Statement
The University of California, San Diego provided partial financial support for the work reported on in this paper. No outside support was received.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
No IRB approval required as only publicly available (non-individual identifiable) data (e.g., daily state-level COVID deaths) used.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Funding: The University of California, San Diego provided partial financial support for the work reported on in this paper. No outside support was received.
Competing interests: The authors declare no competing interests
Data Availability
All data and code from the paper will be archived at github before publication.
